{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=64035", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=64035", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=64035&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=64035&_page=0", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=64035", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=64035", "items" : [{"_about" : "http://data.parliament.uk/resources/1522764", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1522764/answer", "answerText" : {"_value" : "<p>The Voluntary Scheme for Branded Medicines Pricing and Access includes a 36 month exemption from payments for drugs containing a new active substance, starting once the marketing authorisation has been granted. Treatment of new active substances under a future voluntary scheme is subject to negotiation.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4320", "label" : {"_value" : "Biography information for Robert Jenrick"}
        }
        , "answeringMemberConstituency" : {"_value" : "Newark"}
        , "answeringMemberPrinted" : {"_value" : "Robert Jenrick"}
        , "dateOfAnswer" : {"_value" : "2022-10-25", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-10-25T16:47:32.28Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-10-17", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the Voluntary scheme for branded medicines pricing and access, whether her Department has made an assessment of the potential merits of an exemption from payments for new active substances from that scheme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3985", "label" : {"_value" : "Biography information for Robert Halfon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Harlow"}
      , "tablingMemberPrinted" : [{"_value" : "Robert Halfon"}
      ], "uin" : "64035"}
    , {"_about" : "http://data.parliament.uk/resources/690320", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/690320/answer", "answerText" : {"_value" : "\u200b<p>The Foreign &amp; Commonwealth Office does not provide direct support for care in the community for the elderly in China. However, this financial year the Foreign and Commonwealth Office has funded three projects that relate to the provision of care to the elderly in China, which all involve collaboration between UK and Chinese partners in the healthcare sector.<\/p><p> <\/p><p>The three projects amount to £200,000. It is worth noting that in December British organisations signed deals worth in excess of £100 million during the largest ever healthcare trade mission to China. Given wider demographic trends, the elderly care sector in China is an area of potential future commercial opportunity, to which UK providers are well-placed to respond. Sharing world class British expertise in public healthcare will therefore help to create further commercial opportunities for UK companies in China, which in turn will help safeguard and create jobs in the UK and strengthen the healthcare sector in the UK.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4014", "label" : {"_value" : "Biography information for Sir Alok Sharma"}
        }
        , "answeringMemberConstituency" : {"_value" : "Reading West"}
        , "answeringMemberPrinted" : {"_value" : "Alok Sharma"}
        , "dateOfAnswer" : {"_value" : "2017-02-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-02-22T17:32:16.313Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "16"}
      , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"}
      , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"}
      , "date" : {"_value" : "2017-02-17", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "China: Older People"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, what support his Department provides for care in the community for the elderly in China.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4385", "label" : {"_value" : "Biography information for Dr Philippa Whitford"}
      }
      , "tablingMemberConstituency" : {"_value" : "Central Ayrshire"}
      , "tablingMemberPrinted" : [{"_value" : "Dr Philippa Whitford"}
      ], "uin" : "64035"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}